New legislation to promote paediatric studies for new cancer medicines.

Hwang, Thomas J; Bourgeois, Florence T

Hwang, Thomas J; Bourgeois, Florence T.

Afiliação

Hwang TJ; Pediatric Therapeutics and Regulatory Science Initiative, Computational Health Informatics Program, Boston Children's Hospital, Boston, MA, USA; Cancer Innovation and Regulation Initiative, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Division of Urological Surgery, Brigham and Women's Hospital, Boston, MA 02115, USA. Electronic address: tjhwang@post.harvard.edu.
Bourgeois FT; Pediatric Therapeutics and Regulatory Science Initiative, Computational Health Informatics Program, Boston Children's Hospital, Boston, MA, USA; Department of Pediatrics, Harvard Medical School, Boston, MA, USA.

Lancet Oncol ; 23(8): e368-e369, 2022 08.

Article em En | MEDLINE | ID: mdl-35901829

Assuntos

Legislação de Medicamentos; Neoplasias; Criança; União Europeia; Humanos; Neoplasias/tratamento farmacológico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Legislação de Medicamentos / Neoplasias Limite: Child / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google